Clarity Pharma’s Shares Plunge 20% as Investor Confidence Shuts Down
Clarity Pharma’s shares plunge 5.9%, leaving a 20% market‑cap hit and thin liquidity—investors face a pivotal AGM and urgent governance scrutiny.
- CLARITY PHARMACEUTICALS LTD
- Australia
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read